Effects of losartan/hydrochlorothiazide on serum uric acid levels and blood pressure in hypertensive patients

Nucleosides, Nucleotides and Nucleic Acids

Volumn 30, Issue 12, 2011, Pages 1030-1034

  Fujimori, S ^a   Oka, Y ^a   Ogata, N ^a   Eto, K ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Hydrochlorothiazide; Losartan; Uric acid

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; LOSARTAN; TRICHLORMETHIAZIDE; URIC ACID;

AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRACTICE GUIDELINE; URIC ACID BLOOD LEVEL;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MALE; URIC ACID;

EID: 84855909310     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.628356     Document Type: Article

References (7)

1. Shimosawa, T.; Gohchi, K.; Yatomi, Y.; et al. Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: Losartan/ hydrochlorothiazide vs. candesartan/amlodipine. Hypertens. Res. 2007, 30, 831-837. (Pubitemid 47578245)
2. Kita, T.; Yokota, N.; Ichiki, Y.; et al. One-year effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors. Hypertens. Res. 2010, 33, 320-325.
3. Minami, J.; Furukawa, S.; Ishimitsu, T.; et al. Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/ hydrochlorothiazide in patients with mild to moderate hypertension. Int. Heart. J. 2009, 50, 85-93.
4. Alderman, M. H.; Cohen, H.; Madhavan, S.; et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999, 34, 144-150. (Pubitemid 29325733)
5. Hoieggen, A.; Alderman, M. H.; Kjeldsen, S. E.; et al. LIFE study group: The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney. Int. 2004, 65, 1041-1049. (Pubitemid 38251080)
6. Franse, L. V.; Pahor, M.; Di, Bari, M.; et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J. Hypertens. 2000, 18, 1149-1154.
7. Japanese Society of Gout and Nucleic Acid Metabolism. Guidelines for the Management of Hyperuricemia and Gout (in Japanese), 2nd ed, 2010.